Interaction of chemotherapy and biological response modifiers in the treatment of melanoma.
Anderson
C M
CM
Department of Medical Oncology, University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA.
Buzaid
A C
AC
Grimm
E A
EA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology
D000276:Adjuvants, Immunologic; D007155:Immunologic Factors; D016898:Interferon-alpha; D007376:Interleukin-2